OCELLBIO

OCELLBIO β€” MEDICAL CELL R&D

We Research Anti-Aging, Beyond the Cell

OCELLBIO is MediShift's dedicated medical R&D subsidiary, covering the full spectrum of anti-aging infrastructure β€” from autologous activated cell therapy to cultured cell supply and clean room construction.

A Medical R&D Corporation Founded by MediShift

OCELLBIO is a core subsidiary established in July 2026 by MediShift, a specialized medical service organization (MSO), to strengthen its expertise in the bio-healthcare business.

Building on strong synergy with Ocell Clinic, a premium medical brand that recently opened, OCELLBIO researches and delivers next-generation anti-aging treatment value that awakens the latent regenerative potential of cell tissue.

OCELLBIO focuses on Cell Therapy R&D.

Safety and Quality

We manage cultured cells through standardized processes in clean room and clean booth environments that meet international standards.

Inherited Clinical Experience

We have a stable technological foundation built on the know-how of researchers with 29 years of research experience at Ajou University.

Synergy with Ocell Clinic

Through collaboration with premium medical brand Ocell Clinic, we provide solutions proven in clinical practice.

GLOBAL VISION

Setting the Global Standard for Medical Infrastructure

Starting with Ocell Clinic, which partners with more than 10 chain hospitals across Korea including Busan and Jeju, we plan to export our core technology and infrastructure to overseas markets such as China and Dubai.

View Partner Network

BEYOND CELL

Beyond the Cell, New Possibilities

Through cultured cell supply and clean system construction, OCELLBIO will elevate the standards of stem cell centers at hospitals and clinics nationwide, and broadly deliver premium, globally competitive anti-aging solutions.

Partnership Inquiry

If you are interested in collaborating on cultured cell supply, clean room/clean booth construction, or technology partnerships, please contact us using the form below.